Cargando…
Prenatal transplantation of human amniotic fluid stem cell could improve clinical outcome of type III spinal muscular atrophy in mice
Spinal muscular atrophy (SMA) is a single gene disorder affecting motor function in uterus. Amniotic fluid is an alternative source of stem cell to ameliorate SMA. Therefore, this study aims to examine the therapeutic potential of Human amniotic fluid stem cell (hAFSC) for SMA. Our SMA model mice we...
Autores principales: | Shaw, Steven W., Peng, Shao-Yu, Liang, Ching-Chung, Lin, Tzu-Yi, Cheng, Po-Jen, Hsieh, T’sang-T’ang, Chuang, Hao-Yu, De Coppi, Paolo, David, Anna L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8080644/ https://www.ncbi.nlm.nih.gov/pubmed/33911155 http://dx.doi.org/10.1038/s41598-021-88559-z |
Ejemplares similares
-
Amniotic Fluid Disorders: From Prenatal Management to Neonatal Outcomes
por: Huri, Mor, et al.
Publicado: (2023) -
In utero therapy for congenital disorders using amniotic fluid stem cells
por: Ramachandra, Durrgah L., et al.
Publicado: (2014) -
Corrigendum: In utero therapy for congenital disorders using amniotic fluid stem cells
por: Ramachandra, Durrgah L., et al.
Publicado: (2015) -
Non-invasive prenatal diagnosis of spinal muscular atrophy by relative haplotype dosage
por: Parks, Michael, et al.
Publicado: (2017) -
Amniotic fluid disorders and the effects on prenatal outcome: a retrospective cohort study
por: Bakhsh, H., et al.
Publicado: (2021)